ORGANIZATIONAL DESIGN OF SQUARE PHARMACEUTICALS LTD. BASED ON 2006 - 2007 COMPANY ACTIVITIES April 20, 2008
Words: 4202 - Pages: 17
has been prepared on the basis of the four annual report of a reputed company, “Techno Drugs Pharmaceutical” in respect to our partial MBA program. We have chosen four consecutive years 2005, 2006, 2007 and 2008 to analyze the ratios, and conduct a DuPont analysis to find the competitive position and the level of performance of both the organizations in respect to the calculated ratios. In addition we have done index analysis of both balance sheet and income statement to find the position of the
Words: 6669 - Pages: 27
Internship Report On “GSK’S Financial Performance Trend Analysis” Azizur Rahman Submitted By:- 08104091 _ _ _ _ _ _ _ _ _ _ _ _ _ 400 BUS – Spring 2012 . Jabir Al Mursalin Submitted To:- MdLecturer of BRAC Business School BRAC University
Words: 10391 - Pages: 42
Internship Report On “GSK’S Financial Performance Trend Analysis” Submitted By:- Azizur Rahman 08104091 _____________ BUS – 400 Spring 2012 Submitted To:- Md. Jabir Al Mursalin Lecturer of BRAC Business School BRAC University Date of Submission: 24 May, 2012 Dept: BBS th Letter of Endorsement The Internship Report entitled GSK’S Financial Performance Trend Analysis has been submitted for partial fulfillment of the requirements for the degree of Bachelor of Business Administration
Words: 10563 - Pages: 43
An Analysis on Ratio of Beximco Pharmaceuticals Limited Letter of Transmittal 7th April, 2013 To, Mahabuba Rahman Lecturer of Finance IBAIS University House # 21/A, Road # 16 (Old-27) Dhanmondi, Dhaka 1209 Dear Madam, Here is the recommendation report on Ratio Analysis of “BEXIMCO PHARMACEUTICALS LTD.” As you read the report, you will get some idea about the pharmaceuticals industry of Bangladesh through our concerned organization. This report contains all the necessary information
Words: 5787 - Pages: 24
used strategic models: 1. PEST analysis 2. STEER Analysis 3. Five Forces Model 4. Strategic Group Map 5. SWOT analysis 6. Blue Ocean Strategies 7. Open innovation 8. McKinsey seven S model Company Detailed Profile including mission & vision and Organogram Company Detail Profile Square pharmaceutical is now the most leading company in Bangladesh since 1985 and is now on its way to becoming a high performance global player. Today it has achieved
Words: 5122 - Pages: 21
1-EXECUTIVE SUMMARY: Ratio analysis is the most important tools for measuring the organization financial performance. A good analyst must use different ratios as a mechanism for evaluating the organization’s performance which is helped the investors to take a better decision of their investment. In our term paper, this report is an assigned job as a partial fulfillment of course requirement by honorable Course teacher Shaikh Masrick Hasan, Lecturer, Adjunct Faculty, ASA University Bangladesh. It is the optimum
Words: 5921 - Pages: 24
Chapter 1 Introduction 1.0 Introduction Financial analysis and performance evaluation of a company are vital facts for any company in today’s world. It includes different aspects of the company. This analysis assesses the viability, stability and profitability of the company. At some level every business decision involves financial analysis and valuation. Outside the firm, security analysts conduct financial analysis and valuation to support their buy/sell decision. This is necessary to price
Words: 10980 - Pages: 44
SUMMARY Square Pharmaceutical Limited Bangladesh is one of the leading pharmaceuticals in Bangladesh. SQUARE today symbolizes a name – a state of mind. But its journey to the growth and prosperity has been no bed of roses. From the inception in 1958, it has today burgeoned into one of the top line conglomerates in Bangladesh. Square Pharmaceuticals Ltd., the flagship company, is holding the strong leadership position in the pharmaceutical industry of Bangladesh since 1985 and is now on
Words: 2256 - Pages: 10
------------------------------------------------- Financial STatement analysis GlaxoSmithKline Limited Company June 15, 2015 GROUP: 6 | SL.No | Name | ID | Remarks | 1. | Md. Arif Hossain | 20-066 | | 2. | Abdullah-Al-Noman | 20-128 | | 3. | Md. Abdul Hamid | 20-110 | | 4. | Rasheduzzaman | 20-070 | | 5. | Md. AmanUllah | 20-116 | | 6. | SumiAkterRitu | 20-030 | | | | | Prepared for: | Tanvir Hamim | Lecturer | Department of Banking and Insurance | Faculty
Words: 4743 - Pages: 19
